DalsnaFinance › IPOs › Avalyn Pharma Inc.
Avalyn Pharma Inc. completed its initial public offering on NASDAQ on April 30, 2026, pricing at $18.00 a share.
| Ticker | AVLN |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | April 30, 2026 |
| Offering price | $18.00 |
| Shares offered | 16,666,667 |
| Total raised | $300M |
IPO data is compiled from SEC filings. This page is general information, not investment advice.